System for respiratory disorder therapy with selection of stimulation strategies

Patent metadata

Field	Value
Publication number	US-10292897-B2
Application number	US-201514961348-A
Country	US
Kind code	B2
Filing date	Dec 7, 2015
Priority date	Dec 8, 2014
Publication date	May 21, 2019
Grant date	May 21, 2019

Abstract

A system includes a processor configured to generate stimulation control signals in response to a detection of a respiratory disorder. The system further includes at least one kinesthetic effector with a vibrating electromechanical transducer applied to a site on a patient's skin for delivering a kinesthetic stimulation energy determined by the control signals. The processor is further configured to determine the effectiveness of a stimulation by detecting a disappearance of the respiratory disorder. The processor is further configured to determine a therapy by selecting a stimulation strategy among several stimulation strategies according to a type of expected or detected disorder.

First claim

What is claimed is:

1. A system for treating a breathing disorder in a patient by stimulation, including:
a processor configured to:
receive respiratory data for the patient from a device configured to measure physiological signals;
detect a respiratory disorder based on the respiratory data; and
generate stimulation control signals in response to the detection of a respiratory disorder; and

at least one effector adapted to receive the stimulation control signals and to deliver a stimulation energy determined by the control signals,
wherein the processor is further configured to provide automatic therapy determination comprising dynamically selecting, according to a type of expected or detected respiratory disorder, a stimulation strategy from a set of stored stimulation strategies, and
wherein the processor is further configured to:
continue delivery of the stimulation energy for a predetermined period of time following the detection of a cessation of the respiratory episode;
detect if an additional respiratory episode occurs during the period of time; and
update a length of the predetermined period of time based on the detection of the additional respiratory episode.

2. The system of claim 1 , wherein the set of stored stimulation strategies comprises at least one stimulation strategy having stimulation pulses of a first type and at least one stimulation strategy having stimulation pulses of a second type;
wherein the pulses of the second type have at least one of a pulse duration greater than the pulses of the first type or a time interval between the pulses of the second type greater than a time interval between the pulses of the first type.

3. The system of claim 2 , wherein:
the pulse duration of the pulses of the first type is between 2 and 3 seconds and the time interval between the pulses of the first type is between 2 and 3 seconds.

4. The system of claim 1 , wherein the automatic therapy determination further comprises limiting a value of the stimulation energy to a maximum value.

5. The system of claim 1 , wherein dynamically selecting the stimulation strategy comprises selecting a high energy stimulation strategy corresponding to a late type of therapy or selecting a low energy stimulation strategy corresponding to an early type of therapy depending on the type of expected or detected respiratory disorder.

6. The system of claim 1 , wherein the automatic therapy determination further comprises:
applying stimulation energy to the patient at an initial energy level; and
in response to continued detection of the respiratory disorder, incrementally raising an energy level of the stimulation energy until the respiratory disorder is not detected or the stimulation energy reaches a maximum value.

7. The system of claim 6 , wherein the automatic therapy determination further comprises comparing the energy level to the maximum value in response to incrementally raising the energy level.

8. The system of claim 7 , wherein the automatic therapy determination further comprises forcing the energy level of the stimulation energy greater than the maximum value when an episode of severe respiratory disorder is detected.

9. The system of claim 1 , wherein the stimulation energy is a kinesthetic stimulation.

10. The system of claim 9 , wherein the at least one effector comprises at least one kinesthetic effector adapted to be applied to a patient's external skin site and comprising a vibrating electromechanical transducer.

11. The system of claim 1 , further comprising the device configured to measure physiological signals.

12. The system of claim 11 , wherein the device is a Holter device.

13. The system of claim 12 , further comprising at least one sensor for measuring physiological signals, wherein the at least one sensor is connected to the Holter device.

14. A system for treating a breathing disorder in a patient by kinesthetic stimulation, including:
a processor configured to:
receive respiratory data for the patient from a device configured to measure physiological signals;
detect a respiratory disorder based on the respiratory data; and
generate kinesthetic stimulation control signals in response to detection of a respiratory disorder; and

at least one kinesthetic effector adapted to be applied to a patient's external skin site, and comprising a vibrating electromechanical transducer adapted to receive control signals and to deliver a kinesthetic stimulation energy determined by said control signals;
wherein the processor is further configured to provide automatic therapy determination comprising dynamically selecting, according to a type of expected or detected respiratory disorder, a stimulation strategy from a set of stored stimulation strategies, and
wherein the processor is further configured to:
continue delivery of the stimulation energy for a predetermined period of time following the detection of a cessation of the respiratory episode;
detect if an additional respiratory episode occurs during the period of time; and
update a length of the predetermined period of time based on the detection of the additional respiratory episode.

15. The system of claim 14 , further comprising the device configured to measure physiological signals.

16. The system of claim 15 , wherein the device is a Holter device.

17. The system of claim 16 , further comprising at least one sensor for measuring physiological signals, wherein the at least one sensor is connected to the Holter device.

Assignees

• Sorin Crm Sas
• Inserm—Institut De La Rech Medicale
• Univ Joseph Fourier
• Univ Rennes

Inventors

• Amblard Amel
• Graindorge Laurence
• Feuerstein Delphine
• Hernandez Alfredo
• Pépin Jean-Louis

Classifications

• A61H2201/5058

  Sensors or detectors · CPC title

• A61H2230/065

  used as a control parameter for the apparatus · CPC title

• A61B5/4818

  Sleep apnoea · CPC title

• A61H2230/207

  partial O2-value · CPC title

• A61H2201/5015

  using specific interfaces or standards, e.g. USB, serial, parallel · CPC title